Retrieve available abstracts of 8 articles: HTML format
Single Articles
August 2025
MARSTON NA, Bergmark BA, Alexander VJ, Karwatowska-Prokopczuk E, et al Design and rationale of the CORE-TIMI?72a and CORE2-TIMI?72b trials of olezarsen
in patients with severe hypertriglyceridemia.
Am Heart J. 2025;286:125-135. PubMedAbstract available
March 2025
BERGMARK BA, Marston NA, Prohaska TA, Alexander VJ, et al Olezarsen in Patients with Hypertriglyceridemia at High Cardiovascular Risk:
Rationale and Design of the Essence-TIMI 73b Trial.
Am Heart J. 2025 Mar 11:S0002-8703(25)00072-9. doi: 10.1016/j.ahj.2025. PubMedAbstract available
February 2025
TIAN Y, Wang X, Hu Z, Yu X, et al Design, rationale, and characterization of the Mobile health based OccuPational
cardiovascular risk intErventioN study (mHealth-OPEN Study).
Am Heart J. 2025 Feb 13:S0002-8703(25)00035-3. doi: 10.1016/j.ahj.2025. PubMedAbstract available
December 2024
IKEMURA N, Chan PS, Gosch K, Nguyen DD, et al Health Status Outcomes after Acute Myocardial Infarction in Patients without
Standard Modifiable Risk Factors.
Am Heart J. 2024 Dec 3:S0002-8703(24)00317-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
October 2024
VASSY JL, Brunette CA, Yi T, Harrison A, et al Design and pilot results from the Million Veteran Program Return Of Actionable
Results (MVP-ROAR) Study.
Am Heart J. 2024;276:99-109. PubMedAbstract available
May 2024
NICHOLLS SJ, Nelson AJ, Ditmarsch M, Kastelein JJP, et al Obicetrapib on Top of Maximally Tolerated Lipid-Modifying Therapies in
Participants With or at High Risk for Atherosclerotic Cardiovascular Disease:
Rationale and Designs of BROADWAY and BROOKLYN.
Am Heart J. 2024 May 3:S0002-8703(24)00116-9. doi: 10.1016/j.ahj.2024. PubMedAbstract available
October 2023
ALNEWAIS ME, Adams L, Alfehaid AS, Alzaidi S, et al Geographic distribution of United States clinical trial sites utilized for
guideline changing studies of cholesterol management.
Am Heart J. 2023;264:174-176. PubMedAbstract available
January 2023
SAITO Y, Inohara T, Kohsaka S, Wada H, et al Characteristics and outcomes of patients with no standard modifiable risk factors
undergoing primary revascularization for acute myocardial infarction: Insights
from the nationwide J-PCI registry.
Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023. PubMedAbstract available